Welcome to our dedicated page for MOODYS /DE/ SEC filings (Ticker: MCO), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on MOODYS /DE/'s stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into MOODYS /DE/'s regulatory disclosures and financial reporting.
Moody’s Corporation disclosed that Stephen Tulenko, President of Moody’s Analytics, has submitted his resignation as an officer and employee of the company. He notified Moody’s on August 19, 2025, that his departure will be effective on September 2, 2025, or an earlier date if determined by the Chief Executive Officer. The filing does not describe any replacement or changes to his responsibilities beyond the resignation notice.
Robert Fauber, President and CEO and a director of Moody's Corporation (MCO), reported option exercises and a sale on 08/15/2025 under a Rule 10b5-1 plan adopted July 30, 2024. He exercised employee stock options with exercise prices of $80.81, $94.18 and $113.34, increasing his reported option holdings and resulting in recorded additions of 56, 134 and 91 shares (as shown on the form). The filing also reports a sale of 415 shares at $521.45, leaving reported beneficial ownership of 61,617.984 shares following the transactions. The Form 4 was signed by a power of attorney for Mr. Fauber on 08/18/2025.
Form 144 notice from Moody's Corporation (MCO) reports a proposed Rule 144 sale of 415 common shares through Fidelity Brokerage Services with an aggregate market value of $216,401.75, scheduled approximately for 08/15/2025 on the NYSE. The filing shows there are 179,400,000 shares outstanding, and documents how the shares were acquired: 134 shares vested as restricted stock on 03/01/2024 (compensation) and the remainder tied to option grants dated 2016–2017 with cash payment dates of 08/15/2025. The notice also lists six prior sales by Robert Fauber in the past three months, each for 415 shares, with gross proceeds shown for each transaction. The filer attests to lack of undisclosed material adverse information.
Form 144 filing – Moody’s Corporation (MCO) reveals CEO Robert Fauber intends to sell 415 common shares on 01 Aug 2025 through Fidelity Brokerage, valued at approximately $211,729. The shares represent just 0.0002 % of the 179.4 million shares outstanding, implying negligible dilution risk.
The planned sale stems from recent equity awards: 134 shares vested as restricted stock on 03 Mar 2024 and 281 shares were acquired via option exercises granted between 2016-2017. The notice also discloses that during the past three months Fauber executed six identical transactions of 415 shares each, totaling 2,490 shares for gross proceeds of roughly $1.20 million.
The filer affirms no undisclosed adverse information and may be operating under a Rule 10b5-1 plan. Given the limited size relative to market float and historical trading volume, the transaction is viewed as routine portfolio diversification with immaterial impact on Moody’s valuation.
Form 4 shows Moody's Analytics President Stephen T. Tulenko executed two open-market sales of MCO common stock on 07/30/2025. The primary trade disposed of 2,120 shares at $511.18 (~$1.08 million in proceeds), while a fractional adjustment of 0.488 shares at $511.87 followed. After these transactions, Tulenko continues to hold 5,558.382 directly owned shares. No derivative activity or 10b5-1 plan indication was disclosed.